COVID-19 and human papillomavirus: Paradoxical immunity
dc.contributor.author | Demirbas, Abdullah | |
dc.contributor.author | Eker, Hediye | |
dc.contributor.author | Elmas, Omer Faruk | |
dc.contributor.author | Ulutas Demirbas, Gozde | |
dc.contributor.author | Atasoy, Mustafa | |
dc.contributor.author | Tursen, Umit | |
dc.contributor.author | Lotti, Torello | |
dc.date.accessioned | 2025-01-21T16:37:13Z | |
dc.date.available | 2025-01-21T16:37:13Z | |
dc.date.issued | 2021 | |
dc.department | Kırıkkale Üniversitesi | |
dc.description.abstract | Coronavirus disease 2019 (COVID-19) is a multisystemic disease that can cause progressive lung failure, organ dysfunction, and coagulation disorder associated with high mortality and morbidity. COVID-19 is known to either primarily cause skin symptoms or increase existing skin diseases. Human papillomavirus (HPV) is a DNA virus that can cause benign and malignant neoplasms. Mucocutaneous verruca vulgaris are common benign lesions of HPV. Here, we report a case of verruca vulgaris regressed after COVID-19. | |
dc.identifier.doi | 10.1111/jocd.14022 | |
dc.identifier.endpage | 2003 | |
dc.identifier.issn | 1473-2130 | |
dc.identifier.issn | 1473-2165 | |
dc.identifier.issue | 7 | |
dc.identifier.pmid | 33626241 | |
dc.identifier.scopus | 2-s2.0-85102235344 | |
dc.identifier.scopusquality | Q2 | |
dc.identifier.startpage | 2001 | |
dc.identifier.uri | https://doi.org/10.1111/jocd.14022 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12587/24430 | |
dc.identifier.volume | 20 | |
dc.identifier.wos | WOS:000626580000001 | |
dc.identifier.wosquality | Q3 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | Wiley | |
dc.relation.ispartof | Journal of Cosmetic Dermatology | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.snmz | KA_20241229 | |
dc.subject | COVID-19; human papillomavirus; paradoxical immunity | |
dc.title | COVID-19 and human papillomavirus: Paradoxical immunity | |
dc.type | Article |